Global /South Korea /Healthcare /Drug Manufacturers - General /078140
chevron_leftBack
Daebongls.Co.,Ltd. logo

Daebongls.Co.,Ltd.

078140
KRX: 078140 Delayed
10,880KRW -2.2%
7.13 USD
As of 13 June 2026, Daebongls.Co.,Ltd. has a market cap of $81.14M USD, ranking #27028 globally and #1370 in South Korea. It ranks #2421 in the Healthcare sector, and #874 in the Drug Manufacturers - General industry.
Global Rank
27028
Country Rank
1370
Sector Rank
2421
Industry Rank
874
Key Stats
Market Cap
$81.14MUSD
123.39B KRW
Enterprise Value
$110.78MUSD
169.07B KRW
Revenue (TTM)
$67.11MUSD
102.06B KRW
EBITDA (TTM)
$7.74MUSD
11.81B KRW
Net Income (TTM)
$6.61MUSD
10.06B KRW
EBITDA Margin
12%
Profit Margin
9.9%
PE Ratio
12.9
PS Ratio
1.2
PB Ratio
0.7
EV/EBITDA
14.3
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Jin-Oh Park open_in_new
Employees
131
Founded
1986
Website
daebongls.co.kr open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-2.2% 2.7% 6.2% -11% -15% -18%

News

Loading...

Markets

Exchange Ticker Price
Korea Exchange
MIC: XKRX
PRIMARY
078140
대봉엘에스(주)
ISIN: KR7078140001
Shares Out.:
10.948M1 Shares Float: 5.24M2
TV:
SA:
YF:
GF:
BA:
MS:
10,880 KRW
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Daebongls.Co.,Ltd.

Daebongls.Co.,Ltd. engages in the research, development, and production of cosmetics, pharmaceutical raw materials, food and feed products in South Korea and internationally. The company’s Cosmetic Ingredients division offers special cosmetic ingredients comprising fresh green tea, black ginseng water, jeju Gulfweed extract, artemisia capillaris extract, jeju camellia oil, jeju daengyuji extract, jeju basalt volcanic Ash, jeju active complex, and ginseng flower extract; and natural and synthesis cosmetics like moisturizing, skin protection, whitening, anti- aging, skin care, and hair care products, as well as anti-pollution, conditioning, and colorant products. The company’s Pharmaceutical Raw Material division develops the API of respiratory, hypertension, digestive treatments, hyperlipemia treatments, and medicines and supply excipients to domestic companies as an agent for global companies. The company’s Food & Feed division manufactures and distributes functional additives, protein products, amino acids, and vitamins. Daebongls.Co.,Ltd. was founded in 1986 and is headquartered in Incheon, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)
Name
Market Cap diff.
PE
$9.15B
13.91T KRW
11K%
-
$6.77B
10.3T KRW
8K%
1958.1
$5.24B
7.97T KRW
6K%
29.9
298380
$4.96B
7.55T KRW
6K%
-
000100
$4.55B
6.92T KRW
6K%
35.9
$4.44B
6.76T KRW
5K%
-
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
939K%
38.1
JNJ
$547.28B
674K%
26.4
ABBV
$360.63B
444K%
97.4
$321.52B
256.25B CHF
396K%
19.9
AZN
$288.84B
215.59B GBP
356K%
27.6
NOVN
$274.65B
218.9B CHF
338K%
20.5
chevron_leftBack